ALIS	amikacin liposome inhalation suspension
AMK	amikacin
BDQ	bedaquiline
CAMHB	cation-adjusted Mueller-Hinton broth
CLO	clofazimine
CLR	clarithromycin
CLSI	Clinical and Laboratory Standards Institute
DCS	D-cycloserine
DMD	delamanid
DOX	doxycycline
DprE1	Decaprenylphosphoryl-β-D-ribose 2′-epimerase
DST	drug susceptibility testing
EMB	ethambutol
ETO	ethionamide
EVM	enviomycin sulfate
FOX	cefoxitin
gDST	genotypic drug susceptibility testing
GLI	Global Laboratory Initiative
HIV	human immunodeficiency virus
IPM	imipenem
INH	isoniazid
JSTB	The Japanese Society for Tuberculosis and NTM
KAN	kanamycin
LVX	levofloxacin
LZD	linezolid
MDR	multidrug resistant
MIC	minimum inhibitory concentration
MABS	Mycobacterium abscessus species
MAB	Mycobacterium abscessus subsp. abscessus
MAC	Mycobacterium avium–intracellulare complex
MFLX	moxifloxacin
MMA	Mycobacterium abscessus subsp. massiliense
Mtb	Mycobacterium tuberculosis
NTM	non-tuberculosis mycobacteria
OMC	omadacycline
PAS	calcium para-aminosalicylate hydrate
PD	pulmonary disease
pDST	phenotypic drug susceptibility testing
PTO	pretomanid
PZA	pyrazinamide
RGM	rapidly growing mycobacteria
RFB	rifabutin
RIF	rifampin
SGM	slowly growing mycobacteria
STR	streptomycin
STX	sitafloxacin
SXT	trimethoprim-sulfamethoxazole
SZD	stezolid
TB	tuberculosis
WHO	World Health Organization
XDR	extensively drug resistant